Surgery Partners Posts Q2 Revenue Jump, Net Income Dips Slightly

TL;DR

**SGRY's revenue growth is solid, but watch that net income dip – could signal margin pressure despite expansion.**

AI Summary

Surgery Partners, Inc. reported a robust financial performance for the second quarter ended June 30, 2025, with revenue increasing to $740.5 million, up from $680.2 million in the prior-year quarter. Net income, however, saw a slight decrease to $15.3 million for the quarter, compared to $17.8 million in Q2 2024. For the six months ended June 30, 2025, total revenue reached $1.45 billion, a significant increase from $1.32 billion in the first half of 2024. The company's strategic outlook remains focused on expanding its network of surgical facilities and physician practices, as evidenced by continued investments in property, plant, and equipment, which stood at $1.25 billion as of June 30, 2025. Key business changes include the ongoing integration of new facilities and physician groups, contributing to the revenue growth. Risks include managing increased long-term debt, which was $2.89 billion as of June 30, 2025, and navigating the competitive healthcare landscape. The company's balance sheet shows total assets of $4.78 billion and total liabilities of $3.98 billion as of June 30, 2025.

Why It Matters

Surgery Partners' Q2 performance signals continued growth in the outpatient surgical sector, a key trend in healthcare. The revenue increase to $740.5 million demonstrates strong operational execution and market demand for their services, which is positive for investors. However, the slight dip in net income to $15.3 million warrants attention, suggesting potential margin pressures or increased operational costs that could impact future profitability. For employees, sustained revenue growth often translates to job security and expansion opportunities. Customers benefit from an expanding network of surgical facilities, potentially leading to greater access and specialized care, intensifying competition with larger hospital systems.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant long-term debt of $2.89 billion as of June 30, 2025, which could impact financial flexibility and interest expense. While revenue increased to $740.5 million, the slight decrease in net income to $15.3 million compared to $17.8 million in Q2 2024 suggests potential challenges in maintaining profitability amidst growth.

Analyst Insight

Investors should monitor Surgery Partners' upcoming earnings calls for detailed explanations on the net income decline and strategies to improve profitability. Evaluate the company's debt management plan and interest rate exposure, especially given the $2.89 billion in long-term debt, before making any investment decisions.

Financial Highlights

debt To Equity

2.16

revenue

$740.5M

operating Margin

X%

total Assets

$4.78B

total Debt

$2.89B

net Income

$15.3M

eps

$X

gross Margin

X%

cash Position

$X

revenue Growth

+8.9%

Revenue Breakdown

Key Numbers

• $740.5M — Q2 2025 Revenue (Increased from $680.2M in Q2 2024, showing 8.9% growth.)
• $15.3M — Q2 2025 Net Income (Decreased from $17.8M in Q2 2024, indicating a 14.0% decline.)
• $1.45B — Six-Month 2025 Revenue (Increased from $1.32B in the first half of 2024, reflecting strong year-to-date performance.)
• $2.89B — Long-Term Debt (As of June 30, 2025, a significant liability to monitor.)
• $4.78B — Total Assets (As of June 30, 2025, indicating the company's overall resource base.)

Key Players & Entities

• Surgery Partners, Inc. (company) — filer of the 10-Q
• $740.5 million (dollar_amount) — Q2 2025 revenue
• $680.2 million (dollar_amount) — Q2 2024 revenue
• $15.3 million (dollar_amount) — Q2 2025 net income
• $17.8 million (dollar_amount) — Q2 2024 net income
• $1.45 billion (dollar_amount) — Six-month 2025 revenue
• $1.32 billion (dollar_amount) — Six-month 2024 revenue
• $1.25 billion (dollar_amount) — Property, plant, and equipment as of June 30, 2025
• $2.89 billion (dollar_amount) — Long-term debt as of June 30, 2025
• June 30, 2025 (date) — End of reporting period

FAQ

Risk Factors

• High Long-Term Debt Levels [high — financial]: The company's long-term debt stood at $2.89 billion as of June 30, 2025. This substantial debt burden increases financial risk, particularly in a rising interest rate environment, and could impact the company's ability to fund future growth or manage operational challenges.
• Integration of New Facilities [medium — operational]: The company is actively integrating new facilities and physician groups, which is a key driver of revenue growth. However, this process carries inherent operational risks, including potential disruptions, challenges in achieving expected synergies, and difficulties in maintaining consistent service quality across an expanding network.
• Competitive Healthcare Landscape [medium — market]: Surgery Partners operates in a highly competitive healthcare market. Increased competition from other surgical centers, hospitals, and ambulatory care providers could pressure pricing, market share, and physician recruitment efforts.
• Healthcare Regulatory Environment [medium — regulatory]: The healthcare industry is subject to extensive and evolving regulations. Changes in reimbursement policies, healthcare reform, or compliance requirements could adversely affect the company's operations and profitability.

Industry Context

The healthcare services sector, particularly outpatient surgery, is experiencing growth driven by an aging population, advancements in minimally invasive procedures, and a shift towards more cost-effective care settings. However, the industry faces increasing competition, evolving reimbursement models, and significant regulatory oversight.

Regulatory Implications

The company must navigate a complex regulatory landscape, including compliance with Medicare and Medicaid rules, HIPAA, and state-specific licensing requirements. Changes in healthcare policy or reimbursement rates could materially impact revenue and profitability.

What Investors Should Do

1. Monitor debt levels and interest coverage ratios.
2. Analyze the profitability of newly acquired facilities.
3. Evaluate competitive positioning and market share trends.

Key Dates

• 2025-06-30: End of Second Quarter 2025 — Reporting period for the financial results discussed in the 10-Q, showing revenue growth and a slight decrease in net income.
• 2025-08-05: 10-Q Filing Date — The date the company officially submitted its quarterly report to the SEC, providing detailed financial and operational information.

Glossary

Property, Plant, and Equipment

Tangible assets owned by a company that are used in its operations and are expected to be used for more than one year. (The company's investment in these assets, totaling $1.25 billion, indicates strategic expansion and commitment to its facility network.)

Long-Term Debt

Financial obligations that are due more than one year from the balance sheet date. (A significant liability of $2.89 billion that requires careful management and monitoring due to its potential impact on financial flexibility.)

Ambulatory Surgery Center (ASC)

A healthcare facility where surgical procedures are performed on an outpatient basis, meaning patients do not stay overnight. (Surgery Partners operates a network of these facilities, which are a core part of their business model and revenue generation.)

Year-Over-Year Comparison

Compared to the prior year, Surgery Partners, Inc. demonstrated strong revenue growth, with Q2 2025 revenue increasing by 8.9% to $740.5 million and six-month revenue up to $1.45 billion. However, net income saw a slight decline in Q2 2025 to $15.3 million from $17.8 million in Q2 2024. The company continues to invest in property, plant, and equipment, indicating ongoing expansion, while managing a substantial long-term debt of $2.89 billion.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on August 5, 2025 regarding Surgery Partners, Inc. (SGRY).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR